Prokarium’s CEO, Ibs Mahmood, will be presenting at the 41st Annual EAU Congress, London, UK, 13-16th March 2026.

Presentation information:

• Presentation Title: PARADIGM 1 – A multi-center Phase 1 study evaluating the safety and clinical effect of a novel microbial immunotherapeutic (ZH9) in patients with relapsed NMIBC – A first interim review (Abstract ID: A0089)

• Session Title: High-risk NMIBC: Evolving BCG–immunotherapy strategies and technical advances in TURB (Abstract Session 05)

• Session Date and Time: Friday 13th March, 16:20 – 16:56